Back
XTL Biopharmaceuticals Vs. Establishment Labs Holdings Industry Stock Comparison
Sell
44
XTLB
XTL Biopharmaceuticals
Last Price:
2.53
Seasonality Move:
-7.87%
Sell
50
ESTA
Establishment Labs Holdings
Last Price:
47.01
Seasonality Move:
16.32%
Sell
44
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy, Sell or Hold?
- The current XTL Biopharmaceuticals [XTLB] share price is $2.56. The Score for XTLB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- XTLB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Establishment Labs Holdings (ESTA)
is a Sell
Is Establishment Labs Holdings a Buy, Sell or Hold?
- The current Establishment Labs Holdings [ESTA] share price is $47.04. The Score for ESTA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ESTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XTLB Stock Price Chart
What is XTL Biopharmaceuticals's stock price today?
-
The XTL Biopharmaceuticals share price today is $2.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESTA Stock Price Chart
What is Establishment Labs Holdings's stock price today?
-
The Establishment Labs Holdings share price today is $47.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESTA is experiencing slight selling pressure.
XTLB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 48.96 | Sell |
| Chaikin Money Flow: | 1319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.48 - 2.7) | Sell |
| Bollinger Bands (100): | (2.34 - 2.76) | Buy |
ESTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 60.74 | Buy |
| Chaikin Money Flow: | -1145930 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.12 - 45.3) | Buy |
| Bollinger Bands (100): | (40.88 - 51.2) | Buy |
XTLB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.48 | Buy |
| 20-day SMA: | 2.58 | Sell |
| 50-day SMA: | 2.66 | Sell |
| 200-day SMA: | 2.03 | Buy |
| 8-day EMA: | 2.52 | Buy |
| 20-day EMA: | 2.56 | Buy |
| 50-day EMA: | 2.58 | Sell |
| 200-day EMA: | 2.17 | Buy |
ESTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.1 | Buy |
| 20-day SMA: | 42.58 | Buy |
| 50-day SMA: | 43.09 | Buy |
| 200-day SMA: | 43.53 | Buy |
| 8-day EMA: | 42.63 | Buy |
| 20-day EMA: | 42.68 | Buy |
| 50-day EMA: | 43.43 | Buy |
| 200-day EMA: | 45.33 | Buy |
XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Establishment Labs Holdings Earnings Growth & ESTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.20 per share, an increase this year of $0.89 per share, and an increase next year of $1.02 per share.
XTL Biopharmaceuticals Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Establishment Labs Holdings Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||